Breakthrough Trial Shows Exercise as Primary Treatment for Irregular Heartbeat

A landmark clinical trial has revealed that a structured, one-year exercise program can reduce the time patients spend in atrial fibrillation (AFib) by nearly 50 percent, offering new hope to millions living with the world’s most common heart rhythm disorder.

The findings, presented at the European Society of Cardiology Congress 2026 in Munich, Germany, suggest that exercise should be elevated from a general wellness recommendation to a primary medical treatment for AFib — a paradigm shift in how cardiologists approach this chronic condition.

Understanding Atrial Fibrillation and Its Toll

Atrial fibrillation occurs when the heart’s two upper chambers beat out of coordination, creating an irregular rhythm that can interfere with blood flow and increase the risk of blood clots, stroke, and heart failure. Symptoms often include:

• Shortness of breath
• Heart palpitations
• Fatigue and low energy
• Dizziness or lightheadedness

Many AFib patients naturally reduce their physical activity out of fear that exertion could trigger another episode. This creates a dangerous cycle: less fitness leads to worse cardiovascular health, which in turn can worsen AFib burden. The new research directly challenges this avoidance mindset.

The NEXAF Trial: A Closer Look

Led by Dr. Bjarne Nes from the Norwegian University of Science and Technology, the NEXAF trial enrolled 295 participants across three centers in Norway. The average age was 64, and 30 percent were women. All participants had non-permanent AFib and physical activity levels below general health recommendations.

Researchers randomly assigned participants to either usual care or a one-year exercise intervention. The exercise program began with eight supervised, high-intensity sessions over the first four to six weeks. Participants then transitioned to primarily home-based exercise, supported by remote guidance through a smartwatch, mobile app, and web platform.

Critically, every participant received an insertable cardiac monitor — a device placed under the skin that continuously records the heart’s electrical activity. Unlike consumer fitness trackers, this clinical-grade device allowed researchers to precisely measure how much time each person spent in AFib over the full year.

Striking Results That Redefine AFib Care

After one year, the results were compelling:

• 45 percent reduction in AFib burden: The exercise group spent just 3.9 percent of their time in AFib, compared to 7.1 percent in the usual care group.
• Improved cardiorespiratory fitness: Participants in the exercise arm showed measurable gains in fitness and lower resting heart rates.
• 37 percent fewer total hospitalizations: A dramatic reduction in hospital visits across all causes.
• 46 percent fewer AFib-related hospitalizations: Nearly half as many admissions specifically linked to arrhythmia.

“Having hard data proving a 45 percent relative drop in actual atrial fibrillation burden is huge. It moves exercise directly into the category of a primary medical treatment,” said Dr. Rigved Tadwalkar, a board-certified cardiologist at Providence Saint John’s Health Center in Santa Monica, California, who was not involved in the research.

However, the quality-of-life findings were less definitive. Scores improved by 5.6 points in the exercise group versus 4.4 points in usual care, but the difference did not reach statistical significance — suggesting that while exercise clearly reduces arrhythmia, its impact on subjective well-being may be more nuanced.

Why Exercise Works for AFib

The cardiovascular benefits of exercise are well established, but the mechanisms by which it reduces AFib specifically are multifaceted:

Structural and Electrical Remodeling

Regular physical activity improves the heart’s structural integrity, reducing fibrosis and inflammation in atrial tissue. It also enhances autonomic nervous system balance, reducing the sympathetic overdrive that can trigger arrhythmia episodes.

Weight and Blood Pressure Management

Obesity and hypertension are two of the strongest risk factors for AFib. Exercise addresses both simultaneously, lowering the metabolic and hemodynamic stressors that promote irregular heart rhythms.

Improved Vagal Tone

Aerobic fitness increases vagal tone — the parasympathetic influence on the heart — which helps stabilize the electrical signaling in the atria and reduce the frequency of AFib episodes.

A Growing Body of Evidence

The NEXAF findings add to a rapidly expanding research base linking physical activity with improved heart rhythm outcomes:

• A study of 87,000 adults found that low, moderate, and high levels of physical activity were associated with lower risks of stroke and death compared with inactivity — regardless of whether participants had AFib.
• Research involving more than 6,000 people with Fitbit data showed that each additional hour of weekly physical activity was linked to an 11 percent lower risk of developing AFib.

“This study adds more evidence to what we already believe to be true — that exercise improves nearly all aspects of cardiac health, including atrial fibrillation,” said Dr. Rod Passman, professor of medicine and director of the Center for Arrhythmia Research at Northwestern University.

Practical Guidance for AFib Patients

For people living with AFib who want to incorporate exercise safely, experts recommend following the model used in the trial:

• Start with professional support: Consult a cardiologist before beginning or significantly intensifying any exercise program.
• Begin with supervised sessions: Initial guided workouts ensure proper intensity, technique, and safety monitoring.
• Develop an individualized plan: Exercise prescriptions should be tailored to each patient’s fitness level, AFib pattern, and overall health.
• Transition to home or gym exercise with a heart monitor: Wearable technology helps track heart rate and detect irregular rhythms during activity.

“Experiencing an episode during a workout could understandably make someone anxious about exercising or discourage them from continuing,” said Dr. Paul Drury, a cardiologist at MemorialCare Saddleback Medical Center. “That is why individualized exercise plans, appropriate medical evaluation, and reassurance from a health care professional can be important in helping patients stay active safely.”

The Role of Wearable Technology

The trial also underscores the growing role of fitness trackers and smartwatches in managing heart arrhythmias. While consumer devices have limitations — previous research found they can detect many AFib episodes but are less accurate than clinical diagnostic equipment — they offer unprecedented accessibility for long-term monitoring.

“Over the long haul, combining consumer tech like smartwatches with real clinical oversight is what will let us reach millions of heart patients,” Dr. Tadwalkar noted.

Limitations and Future Directions

Despite its promising results, the NEXAF trial has limitations worth noting. The study population was physically inactive, had non-permanent AFib, and was treated exclusively at Norwegian centers — factors that may limit how broadly the findings apply to more diverse populations.

Additionally, the program’s initial high-intensity supervised sessions may not be appropriate for all AFib patients, particularly those with more severe forms of the condition or other comorbidities.

Researchers emphasize that exercise should complement, not replace, medication and other AFib treatments. Future studies will need to replicate these findings across broader demographics and over longer follow-up periods to fully validate exercise as a standard prescription in AFib care protocols.

A New Era in Heart Rhythm Management

The NEXAF trial represents a turning point in how the medical community views the role of lifestyle intervention in treating chronic cardiac conditions. For decades, AFib management has relied primarily on medications, catheter ablation, and device therapy. This research demonstrates that a structured exercise program can deliver reductions in arrhythmia burden comparable to some medical interventions — without the side effects of pharmaceuticals.

As Dr. Drury summarized: “The findings should reassure many people with AFib that being physically active can be both safe and beneficial when exercise is appropriately tailored to their health and fitness level.”

For the estimated 33 million people worldwide living with atrial fibrillation, the message is clear: movement is medicine, and with the right guidance, it may be one of the most powerful tools available to reclaim a steady heartbeat.

---

Edited by Palawan @QUE.COM
Website: https://QUE.COM Intelligence
Sponsored by: https://MAJ.COM AI Autonomous